Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

MitraClip Feasible, Safe, and Produces Promising Early Results in Tricuspid Regurgitation

Shelley Wood

September 19, 2016

News Daily News

La Intervención de Sustitución Mínimamente Invasiva de las Cuerdas de la Válvula Mitral es Prometedora pero está en su Infancia

Shelley Wood

July 20, 2016

News Conference News EuroPCR 2016

‘Europe Isn’t Waiting’: MitraClip Moves Into New Niches, Big and Small

Shelley Wood

May 26, 2016

News Conference News EuroPCR 2016

EuroPCR 2016: Mitral Innovations, LAA Closure, and ‘TAVI, TAVI, TAVI’

Shelley Wood

May 16, 2016

News Conference News CRT 2016

Early Results for Transcatheter Mitral Valve Replacement Reveal Complications and Challenges for the Long Road Ahead

Shelley Wood

February 21, 2016

News Conference News ESC 2015

Registry Provides Support for Use of MitraClip in Lower-Risk Patients

L.A. McKeown

September 01, 2015

Presentation TCT 2014

The Trial Got it So Wrong; For So Many Reasons: Repair Should Still Be Favored in Functional MR!

Presenter: Steven F. Bolling

September 14, 2014

Presentation TCT 2014

The Trial Got it Right: Replacement Is Favored in Functional MR!

Presenter: Michael J. Mack

September 14, 2014

News Daily News

Similar Survival Benefits from Surgery, MitraClip in Symptomatic, High-Risk Mitral Regurgitation

L.A. McKeown

August 20, 2014

News Daily News

MitraClip Benefits High-, Prohibitive-Risk Patients with Mitral Regurgitation

July 10, 2014

News Conference News EuroPCR 2014

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

Caitlin E. Cox

May 28, 2014

News Daily News

MitraClip Appears Safe, Effective for Patients with Noncentral Regurgitatior

L.A. McKeown

September 20, 2013

News Daily News

EVEREST II at 4 Years: Surgery Maintains Early Advantage, But MitraClip Durable

May 17, 2013

News Daily News

EVEREST II a los 4 Años: La Cirugía Mantiene una Ventaja Inicial pero MitraClip es Duradero

May 17, 2013

News Daily News

Close FDA Panel Vote Favors MitraClip for MR Patients with No Other Options

March 25, 2013

Advertisement

MitraClip Feasible, Safe, and Produces Promising Early Results in Tricuspid Regurgitation

La Intervención de Sustitución Mínimamente Invasiva de las Cuerdas de la Válvula Mitral es Prometedora pero está en su Infancia

‘Europe Isn’t Waiting’: MitraClip Moves Into New Niches, Big and Small

EuroPCR 2016: Mitral Innovations, LAA Closure, and ‘TAVI, TAVI, TAVI’

Early Results for Transcatheter Mitral Valve Replacement Reveal Complications and Challenges for the Long Road Ahead

Registry Provides Support for Use of MitraClip in Lower-Risk Patients

The Trial Got it So Wrong; For So Many Reasons: Repair Should Still Be Favored in Functional MR!

The Trial Got it Right: Replacement Is Favored in Functional MR!

Similar Survival Benefits from Surgery, MitraClip in Symptomatic, High-Risk Mitral Regurgitation

MitraClip Benefits High-, Prohibitive-Risk Patients with Mitral Regurgitation

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

MitraClip Appears Safe, Effective for Patients with Noncentral Regurgitatior

EVEREST II at 4 Years: Surgery Maintains Early Advantage, But MitraClip Durable

EVEREST II a los 4 Años: La Cirugía Mantiene una Ventaja Inicial pero MitraClip es Duradero

Close FDA Panel Vote Favors MitraClip for MR Patients with No Other Options

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content